277 related articles for article (PubMed ID: 11177743)
1. Immunotherapy for colorectal cancer.
Foon KA
Curr Oncol Rep; 2001 Mar; 3(2):116-26. PubMed ID: 11177743
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant immunotherapy for melanoma and colorectal cancers.
Safa MM; Foon KA
Semin Oncol; 2001 Feb; 28(1):68-92. PubMed ID: 11254868
[TBL] [Abstract][Full Text] [Related]
3. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
[No Abstract] [Full Text] [Related]
4. Colorectal cancer as a model for immunotherapy.
Foon KA; Yannelli J; Bhattacharya-Chatterjee M
Clin Cancer Res; 1999 Feb; 5(2):225-36. PubMed ID: 10037169
[No Abstract] [Full Text] [Related]
5. The anti-idiotype vaccines for immunotherapy.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
[TBL] [Abstract][Full Text] [Related]
6. Biological therapy of colorectal cancer.
de Kleijn EM; Punt CJ
Eur J Cancer; 2002 May; 38(7):1016-22. PubMed ID: 11978526
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
[TBL] [Abstract][Full Text] [Related]
8. A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.
Ullenhag GJ; Spendlove I; Watson NF; Indar AA; Dube M; Robins RA; Maxwell-Armstrong C; Scholefield JH; Durrant LG
Clin Cancer Res; 2006 Dec; 12(24):7389-96. PubMed ID: 17121873
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotype vaccine against cancer.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody.
Denton GW; Durrant LG; Hardcastle JD; Austin EB; Sewell HF; Robins RA
Int J Cancer; 1994 Apr; 57(1):10-4. PubMed ID: 8150527
[TBL] [Abstract][Full Text] [Related]
11. Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.
Zbar AP; Thomas H; Wilkinson RW; Wadhwa M; Syrigos KN; Ross EL; Dilger P; Allen-Mersh TG; Kmiot WA; Epenetos AA; Snary D; Bodmer WF
Int J Colorectal Dis; 2005 Sep; 20(5):403-14. PubMed ID: 15864608
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in immunotherapy for the treatment of colorectal cancer.
Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
[TBL] [Abstract][Full Text] [Related]
13. Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Bhattachary-Chatterjee M; Nath Baral R; Chatterjee SK; Das R; Zeytin H; Chakraborty M; Foon KA
Cancer Immunol Immunother; 2000 Jun; 49(3):133-41. PubMed ID: 10881692
[TBL] [Abstract][Full Text] [Related]
14. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
Posner MC; Niedzwiecki D; Venook AP; Hollis DR; Kindler HL; Martin EW; Schilsky RL; Goldberg RM; Mayer RJ
Ann Surg Oncol; 2008 Jan; 15(1):158-64. PubMed ID: 18008108
[TBL] [Abstract][Full Text] [Related]
15. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.
Robins RA; Denton GW; Hardcastle JD; Austin EB; Baldwin RW; Durrant LG
Cancer Res; 1991 Oct; 51(19):5425-9. PubMed ID: 1913661
[TBL] [Abstract][Full Text] [Related]
16. [Immunotherapy for colorectal cancer].
Tougeron D; Fauquembergue É; Latouche JB
Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cancer patients' immune responses by anti-idiotypic antibodies.
Herlyn D; Wettendorff M; Koprowski H
Int Rev Immunol; 1989; 4(4):347-57. PubMed ID: 2519932
[TBL] [Abstract][Full Text] [Related]
18. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.
Fagerberg J; Steinitz M; Wigzell H; Askelöf P; Mellstedt H
Proc Natl Acad Sci U S A; 1995 May; 92(11):4773-7. PubMed ID: 7539133
[TBL] [Abstract][Full Text] [Related]
19. Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.
Maxwell-Armstrong C
Ann R Coll Surg Engl; 2002 Sep; 84(5):314-8. PubMed ID: 12398121
[TBL] [Abstract][Full Text] [Related]
20. Active specific immunotherapy for colorectal cancer.
Indar AA; Maxwell-Armstrong CA
Expert Rev Anticancer Ther; 2003 Oct; 3(5):685-94. PubMed ID: 14599091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
